180 related articles for article (PubMed ID: 35072863)
1. Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making.
Marchegiani G; Crippa S; Perri G; Rancoita PMV; Caravati A; Belfiori G; Dall'Olio T; Aleotti F; Partelli S; Bassi C; Falconi M; Salvia R
Ann Surg Oncol; 2022 May; 29(5):3206-3214. PubMed ID: 35072863
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of conservative surgery for pancreatic IPMNs.
Palmeri M; Di Franco G; Bianchini M; Guadagni S; Gianardi D; Furbetta N; Caprili G; Fatucchi LM; Sbrana A; Funel N; Pollina LE; Di Candio G; Morelli L
Surg Oncol; 2021 Sep; 38():101582. PubMed ID: 33892432
[TBL] [Abstract][Full Text] [Related]
3. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
4. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Kuwahara T; Hara K; Mizuno N; Okuno N; Matsumoto S; Obata M; Kurita Y; Koda H; Toriyama K; Onishi S; Ishihara M; Tanaka T; Tajika M; Niwa Y
Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31117111
[TBL] [Abstract][Full Text] [Related]
8. [Limited pancreatic resections for intraductal papillary mucinous neoplasm].
Blanc B; Sauvanet A; Couvelard A; Pessaux P; Dokmak S; Vullierme MP; Lévy P; Ruszniewski P; Belghiti J
J Chir (Paris); 2008; 145(6):568-78. PubMed ID: 19106888
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy.
Hashimoto D; Satoi S; Yamamoto T; Yamaki S; Ishida M; Hirooka S; Shibata N; Boku S; Ikeura T; Sekimoto M
Pancreatology; 2022 Nov; 22(7):1046-1053. PubMed ID: 35871123
[TBL] [Abstract][Full Text] [Related]
10. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P
Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561
[TBL] [Abstract][Full Text] [Related]
11. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
[TBL] [Abstract][Full Text] [Related]
12. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
13. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.
Fuji T; Umeda Y; Takagi K; Yoshida R; Yoshida K; Yasui K; Matsumoto K; Kato H; Yagi T; Fujiwara T
BMC Cancer; 2022 May; 22(1):588. PubMed ID: 35643422
[TBL] [Abstract][Full Text] [Related]
14. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
Marchegiani G; Pollini T; Andrianello S; Tomasoni G; Biancotto M; Javed AA; Kinny-Köster B; Amini N; Han Y; Kim H; Kwon W; Kim M; Perri G; He J; Bassi C; Goh BK; Katz MH; Jang JY; Wolfgang C; Salvia R
JAMA Surg; 2021 Jul; 156(7):654-661. PubMed ID: 34009303
[TBL] [Abstract][Full Text] [Related]
15. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation.
Manuel-Vázquez A; Balakrishnan A; Agami P; Andersson B; Berrevoet F; Besselink MG; Boggi U; Caputo D; Carabias A; Carrion-Alvarez L; Franco CC; Coppola A; Dasari BVM; Diaz-Mercedes S; Feretis M; Fondevila C; Fusai GK; Garcea G; Gonzabay V; Bravo MÁG; Gorris M; Hendrikx B; Hidalgo-Salinas C; Kadam P; Karavias D; Kauffmann E; Kourdouli A; La Vaccara V; van Laarhoven S; Leighton J; Liem MSL; Machairas N; Magouliotis D; Mahmoud A; Marino MV; Massani M; Requena PM; Mentor K; Napoli N; Nijhuis JHT; Nikov A; Nistri C; Nunes V; Ruiz EO; Pandanaboyana S; Saborido BP; Pohnán R; Popa M; Pérez BS; Bueno FS; Serrablo A; Serradilla-Martín M; Skipworth JRA; Soreide K; Symeonidis D; Zacharoulis D; Zelga P; Aliseda D; Santiago MJC; Mancilla CF; Fragua RL; Hughes DL; Llorente CP; Lesurtel M; Gallagher T; Ramia JM;
Langenbecks Arch Surg; 2022 Dec; 407(8):3447-3455. PubMed ID: 36198881
[TBL] [Abstract][Full Text] [Related]
16. Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms.
Xu B; Ding WX; Jin DY; Wang DS; Lou WH
World J Gastroenterol; 2013 Mar; 19(9):1451-7. PubMed ID: 23539521
[TBL] [Abstract][Full Text] [Related]
17. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasm--when to resect?
Waters JA; Schmidt CM
Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
[TBL] [Abstract][Full Text] [Related]
19. Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms.
Kaiser J; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW; Hackert T
Surgery; 2017 Mar; 161(3):602-610. PubMed ID: 27884612
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas.
Kuroki T; Adachi T; Ono S; Tanaka T; Kitasato A; Takatsuki M; Eguchi S
Hepatogastroenterology; 2012; 59(120):2631-4. PubMed ID: 22534541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
